Hologic slips after a Q1 EPS and revenue miss, as gross margin fell 150 bps with Diagnostics weakness offset by strong GYN ...

Hologic’s HOLX Skeletal Health division has been driving positive contributions ever since the earlier supply challenges began to ease. Sales jumped 62.1% in the third quarter of fiscal 2025, driven ...

Hologic HOLX is set to release first-quarter fiscal 2026 results on Jan. 29, after the closing bell. The Zacks Consensus Estimate for fiscal first-quarter earnings per share (EPS) suggests a 5.8% ...

Hologic HOLX is set to release fourth-quarter fiscal 2025 results on Nov. 3, after the closing bell. The Zacks Consensus Estimate for fiscal fourth-quarter earnings per share (EPS) suggests an 8.9% ...

Medical technology company Hologic (NASDAQ:HOLX) reported Q2 CY2025 results , with sales up 1.2% year on year to $1.02 billion. The company expects next quarter’s revenue to be around $1.04 billion, ...

Hologic has been outperforming peers but underperforming the broader medical device sector, with shares up about 5% since my last analysis. Fiscal Q3 results showed consistent beats in Diagnostics, ...